Basic/Clinical Science Session
Navigating Human Leukocyte Antigens
November 06, 2025 | 04:30 PM - 06:00 PM
Location: Room 332A, Convention Center
Session Description
Human leukocyte antigen (HLA) crossmatch is a crucial component of pretransplant donor-recipient compatibility assessment. Traditional cell-based crossmatch has played a pivotal role in eliminating the risks of hyperacute antibody-mediated rejection, but there are drawbacks, including false-positive rates, impact on cold ischemia time, and logistical challenges. Virtual crossmatch has been increasingly used in lieu of cell-based crossmatch to address such challenges.
Learning Objective(s)
- Define the role of virtual crossmatch in deceased donor kidney transplantation
- Discuss the current state of desensitization for highly sensitized kidney transplant recipients
- Describe machine-learning approaches to HLA risk stratification
Learning Pathway(s)
- Kidney Transplantation
Moderators
Presentations
- Virtual Crossmatch in Kidney Transplantation: When and How?
04:30 PM - 04:50 PM
- Desensitization in Kidney Transplantation: What's New?
04:50 PM - 05:10 PM
- Use of Advanced HLA Epitope and Eplet Matching to Stratify Immunologic Risk
05:10 PM - 05:30 PM
- Machine-Learning Approaches to HLA-Based Risk Stratification in Kidney Transplantation
05:30 PM - 05:50 PM
- Q&A
05:50 PM - 06:00 PM